Carvedilol for portal hypertension in patients with cirrhosis.
about
Beta-blockers in liver cirrhosisRepurposing of approved cardiovascular drugsPrevention and management of gastroesophageal varices in cirrhosis.The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.Management of varices in cirrhosis.Portal hypertension: pathophysiology, diagnosis, and treatment.Management of varices in patients with cirrhosis.Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).Pathophysiology of portal hypertension and its clinical links.Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.Carvedilol: the β-blocker of choice for portal hypertension?Severe carvedilol toxicity without overdose - caution in cirrhosis.Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.Pharmacologic prevention of variceal bleeding and rebleeding.The renal effects of droxidopa are maintained in propranolol treated cirrhotic ratsCarvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololRole of band ligation for secondary prophylaxis of variceal bleeding
P2860
Q27012922-F2D8D7DA-9A8F-411F-BE64-F9E85777C823Q28074453-0D8AF5E3-7E11-4076-8CDA-7994E5448880Q34638216-2D9AAA12-9EEB-4977-A99A-832A45120D32Q35707623-A32487DB-FF6E-4D30-9C3E-475FE0379994Q36008972-773D1504-DAB7-4871-AF66-DBB05434E44DQ37832507-23B412B8-5FD5-4894-99E7-30141095A208Q37850467-1DDBADC6-EAF2-4D69-9A58-F310689F1A54Q38094881-68F3F306-B9DB-43BF-A557-164269A5F371Q38098443-956BD500-F927-42E7-B041-54F2B5FC8281Q38371453-D019E72B-96C8-47A3-A486-645213DF272DQ38446357-4676672E-B385-48D7-BE2A-49163738A731Q39440287-2E6AC0B9-D2B7-46E5-817B-6A5ED03DA1B8Q41341900-CB11A9BE-C926-483A-828B-7999E04D09A0Q44214021-16A80873-3801-4CFF-9769-E568D0A20C26Q46186827-070D378C-C307-4437-9EDD-0F2E356D8101Q47100753-5A10E3C7-4089-42CC-A5A0-A4147549E906Q47320079-AFB9AC09-4522-4643-A007-5ACC453259E2Q50054841-2306E411-7926-4B46-B803-F0F9AE848450Q57147093-3849FFFA-4E0C-4DCD-919C-45D03BE9758BQ57168135-C10EBB48-7523-4421-8015-35AE5523B6F8Q57176085-F57B76AF-F753-4225-BB31-99EFBAC0F6E2
P2860
Carvedilol for portal hypertension in patients with cirrhosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Carvedilol for portal hypertension in patients with cirrhosis.
@en
Carvedilol for portal hypertension in patients with cirrhosis.
@nl
type
label
Carvedilol for portal hypertension in patients with cirrhosis.
@en
Carvedilol for portal hypertension in patients with cirrhosis.
@nl
prefLabel
Carvedilol for portal hypertension in patients with cirrhosis.
@en
Carvedilol for portal hypertension in patients with cirrhosis.
@nl
P2860
P356
P1433
P1476
Carvedilol for portal hypertension in patients with cirrhosis.
@en
P2093
Jaime Bosch
P2860
P304
P356
10.1002/HEP.23689
P407
P577
2010-06-01T00:00:00Z